 Kazia Therapeutics Ltds ASX:KZA FRA:NV9M NASDAQ:KZIA phase-II study of paxalisib in Primary CNS Lymphoma has been initiated at Dana-Farber Cancer Institute in Boston, Massachusetts, with the first patient enrolled to the study. Lymphoma is a cancer of white blood cells that occurs in the lymphatic system and can spread almost anywhere in the body while primary CNS lymphoma PCNSL occurs exclusively in the brain and central nervous system. 